Drugs Health Pharma

US-based Tome Biosciences to retrench 131 employees 

Tome Biosciences, a US company engaged in gene editing, will lay off 131 employees as it plans to reduce costs, according to a.

Read More
Drugs Health Pharma

US drug regulator approves two treatments for sickle cell disease 

HQ Team December 8, 2023: The USFDA has approved two treatments for sickle cell disease, one of them the first in the US.

Read More
Drugs Health Pharma

Cambridge Univ, AstraZeneca, MRC to set up genomics laboratory

HQ Team November 29, 2023: The University of Cambridge announced a partnership with AstraZeneca and the Medical Research Council to set up a functional genomics laboratory.

Read More
Drugs Health Medical Pharma

Gene therapy cure for sickle cell awaits advisory approval

HQ Team October 28, 2023: Advisers to the Food and Drug Administration (FDA) are set to review a gene therapy for sickle cell.

Read More
Drugs Health Pharma

Biomedical engineers create ML model to turn genes on and off

HQ Team August 14, 2023: Biomedical engineers at Johns Hopkins have developed a machine-learning model, which can turn on genes —an innovation which.

Read More
Drugs Health Medical Pharma

FDA considering approval for first ever CRISPR gene editing technology drug

HQ Team June 10, 2023:The Food and Drug Administration (FDA) has accepted an application for what could become the first-ever marketed medicine based.

Read More
Drugs Medical Pharma

‘Love hormone’ Oxytocin breaks a three-decade-old perception

The receptor of Oxytocin, a hormone considered essential to forming social bonds, may not play the role that scientists have assigned it for.

Read More
X